Skip to content
← Back to this collection

PUBLICATIONS · 23620515

Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Proc Natl Acad Sci U S A
Publication date
2013 May 7
First author
Knutson SK

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Knutson SK
      type
      Author
    2. name
      Warholic NM
      type
      Author
    3. name
      Wigle TJ
      type
      Author
    4. name
      Klaus CR
      type
      Author
    5. name
      Allain CJ
      type
      Author
    6. name
      Raimondi A
      type
      Author
    7. name
      Porter Scott M
      type
      Author
    8. name
      Chesworth R
      type
      Author
    9. name
      Moyer MP
      type
      Author
    10. name
      Copeland RA
      type
      Author
    11. name
      Richon VM
      type
      Author
    12. name
      Pollock RM
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Knutson SK
      type
      Author
    2. name
      Warholic NM
      type
      Author
    3. name
      Wigle TJ
      type
      Author
    4. name
      Klaus CR
      type
      Author
    5. name
      Allain CJ
      type
      Author
    6. name
      Raimondi A
      type
      Author
    7. name
      Porter Scott M
      type
      Author
    8. name
      Chesworth R
      type
      Author
    9. name
      Moyer MP
      type
      Author
    10. name
      Copeland RA
      type
      Author
    11. name
      Richon VM
      type
      Author
    12. name
      Pollock RM
      type
      Author
    bibliography ids
    1. nci-bib-0d749cb1cb39fedc010c4512
    book metadata
    content sha256
    a5f599471dc47f523d247f67e8d35a47eea8ee940ef1eff7a4aaac3cf11ed2c7
    document type
    citation
    dois
    1. 10.1073/pnas.1303800110
    electronic publication date
    display
    2013 Apr 25
    precision
    day
    year
    2013
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:23620515
    immutable id
    pubmed:23620515@a5f599471dc47f523d247f67e8d35a47eea8ee940ef1eff7a4aaac3cf11ed2c7
    journal
    abbreviation
    Proc Natl Acad Sci U S A
    issn electronic
    1091-6490
    issn print
    0027-8424
    issue
    19
    name
    Proceedings of the National Academy of Sciences of the United States of America
    nlm unique id
    7505876
    pages
    7922-7
    volume
    110
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      23620515
      provenance
      batch id
      99e008dabc339d38fd44
      provider
      NCBI PubMed ESummary
      record sha256
      f58fa579464936b22a069a07ee587f2f96c092a4a9f2235c3eb84d0948156a8b
      response sha256
      804916232567480946eda9a00aff276bc44fd9a6d15d9336e773a9c803123d39
      retrieved at
      2026-09-09T23:46:55.094762+00:00
      publication date
      display
      2013 May 7
      precision
      day
      year
      2013
      publication types
      1. Journal Article
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/23620515/
      title
      Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2.

      Preserved source evidence · Independent clinical review pending · Not medical advice